Decoy Therapeutics Statistics
Total Valuation
DCOY has a market cap or net worth of $2.10 million. The enterprise value is -$6.19 million.
| Market Cap | 2.10M |
| Enterprise Value | -6.19M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DCOY has 655,185 shares outstanding. The number of shares has increased by 319.16% in one year.
| Current Share Class | 655,185 |
| Shares Outstanding | 655,185 |
| Shares Change (YoY) | +319.16% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 0.80% |
| Float | 652,071 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.21 |
| Forward PS | n/a |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.83
| Current Ratio | 1.83 |
| Quick Ratio | 1.77 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -827.77% and return on invested capital (ROIC) is -218.37%.
| Return on Equity (ROE) | -827.77% |
| Return on Assets (ROA) | -73.35% |
| Return on Invested Capital (ROIC) | -218.37% |
| Return on Capital Employed (ROCE) | -141.15% |
| Weighted Average Cost of Capital (WACC) | 7.43% |
| Revenue Per Employee | $20,694 |
| Profits Per Employee | -$1.31M |
| Employee Count | 11 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.10% in the last 52 weeks. The beta is 0.58, so DCOY's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -95.10% |
| 50-Day Moving Average | 5.21 |
| 200-Day Moving Average | 7.96 |
| Relative Strength Index (RSI) | 31.45 |
| Average Volume (20 Days) | 84,993 |
Short Selling Information
The latest short interest is 25,246, so 3.85% of the outstanding shares have been sold short.
| Short Interest | 25,246 |
| Short Previous Month | 23,986 |
| Short % of Shares Out | 3.85% |
| Short % of Float | 3.87% |
| Short Ratio (days to cover) | 0.27 |
Income Statement
In the last 12 months, DCOY had revenue of $227,629 and -$14.45 million in losses. Loss per share was -$40.40.
| Revenue | 227,629 |
| Gross Profit | -1.63M |
| Operating Income | -6.10M |
| Pretax Income | -14.45M |
| Net Income | -14.45M |
| EBITDA | -6.07M |
| EBIT | -6.10M |
| Loss Per Share | -$40.40 |
Balance Sheet
The company has $8.29 million in cash and no debt, with a net cash position of $8.29 million or $12.65 per share.
| Cash & Cash Equivalents | 8.29M |
| Total Debt | n/a |
| Net Cash | 8.29M |
| Net Cash Per Share | $12.65 |
| Equity (Book Value) | 4.32M |
| Book Value Per Share | 8.12 |
| Working Capital | 3.89M |
Cash Flow
In the last 12 months, operating cash flow was -$8.32 million and capital expenditures -$42,424, giving a free cash flow of -$8.37 million.
| Operating Cash Flow | -8.32M |
| Capital Expenditures | -42,424 |
| Depreciation & Amortization | 24,495 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.37M |
| FCF Per Share | -$12.77 |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,679.30% |
| Pretax Margin | -6,347.85% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DCOY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -319.16% |
| Shareholder Yield | n/a |
| Earnings Yield | -689.19% |
| FCF Yield | -399.07% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 9, 2026. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 9, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
DCOY has an Altman Z-Score of -16.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.63 |
| Piotroski F-Score | 2 |